# Dysregulated Gene Expression: A Candidate Mechanism for Anxiety Disorders

## TL;DR

This paper reviews how disrupted gene regulation, rather than single gene mutations, may contribute to anxiety disorders, offering new insights into their genetic basis.

## Contribution

The paper highlights gene-regulatory elements as a novel mechanism for anxiety disorders beyond traditional single-gene variants.

## Key findings

- Most GWAS hits for anxiety disorders are in non-coding regions linked to gene regulation.
- Altered gene expression through regulatory elements may disrupt neuronal signaling and stress responses.
- Understanding gene regulation could lead to better diagnosis and treatment of anxiety disorders.

## Abstract

Anxiety disorders are among the most prevalent and debilitating mental illnesses worldwide. While environmental factors such as early-life stress contribute to their etiology, genetics also plays a crucial role, with a family history increasing susceptibility. Unlike Mendelian traits driven by single gene variants, anxiety disorders appear to follow polygenic inheritance in which multiple genetic variants collectively shape risk. Genome-wide association studies (GWAS) have identified numerous loci linked to anxiety, yet individual variants have small effect sizes and leave much of the heritability unexplained. A clue to resolving this conundrum may lie in the fact that most GWAS hits reside in non-coding regions with characteristics of gene-regulatory elements. This observation raises the possibility that altered expression of otherwise normal genes contributes to susceptibility. Gene-regulatory elements control when and where genes are expressed. Disruption of these elements may contribute to anxiety disorders by subtly altering neuronal signaling and stress-response pathways. Unraveling the role of gene regulation in anxiety disorders presents a promising avenue for improved diagnosis and targeted treatments. This review explores recent advances in the field and their potential for understanding the genetic architecture of anxiety disorders.